tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CRBP Stock Latest News

Corbus announces first patient dosed in Phase 1 CRB-913 study
The FlyCorbus announces first patient dosed in Phase 1 CRB-913 study
7d ago
CRBP
Corbus Pharmaceuticals Announces Board Member Departure
PremiumCompany Announcements
Corbus Pharmaceuticals Announces Board Member Departure
14d ago
8K
CRBP
Corbus Pharmaceuticals Appoints Ian Hodgson as COO
PremiumCompany Announcements
Corbus Pharmaceuticals Appoints Ian Hodgson as COO
17d ago
8K
CRBP
Corbus Pharmaceuticals price target lowered to $50 from $75 at H.C. Wainwright
PremiumThe Fly
Corbus Pharmaceuticals price target lowered to $50 from $75 at H.C. Wainwright
23d ago
CRBP
Corbus Pharmaceuticals Advances in Oncology and Obesity
PremiumCompany Announcements
Corbus Pharmaceuticals Advances in Oncology and Obesity
23d ago
CRBP
Corbus Pharmaceuticals price target lowered to $53 from $70 at Jefferies
PremiumThe FlyCorbus Pharmaceuticals price target lowered to $53 from $70 at Jefferies
24d ago
CRBP
Corbus Pharmaceuticals Reports Q4 2024 Financial Results
Premium
Company Announcements
Corbus Pharmaceuticals Reports Q4 2024 Financial Results
24d ago
8K
CRBP
Corbus Pharmaceuticals reports Q4 EPS (78c), consensus ($1.26)
Premium
The Fly
Corbus Pharmaceuticals reports Q4 EPS (78c), consensus ($1.26)
24d ago
CRBP
Elastic, Monster, Caesars, Catalyst, Corbus: Stock Shake-Up!
PremiumWeekend Updates
Elastic, Monster, Caesars, Catalyst, Corbus: Stock Shake-Up!
27d ago
CZR
CPRX
Corbus Pharmaceuticals initiated with an Outperform at William Blair
PremiumThe Fly
Corbus Pharmaceuticals initiated with an Outperform at William Blair
1M ago
CRBP
Corbus Pharmaceuticals: Promising ADC Advancements with CRB-701 and Market Opportunities Amidst Risks
PremiumRatings
Corbus Pharmaceuticals: Promising ADC Advancements with CRB-701 and Market Opportunities Amidst Risks
1M ago
CRBP
Promising Potential of Corbus Pharmaceuticals’ CRB-701 in Oncology: A Strong Buy Rating by Andrew Fein
PremiumRatings
Promising Potential of Corbus Pharmaceuticals’ CRB-701 in Oncology: A Strong Buy Rating by Andrew Fein
2M ago
CRBP
Corbus Pharmaceuticals Reports Promising Phase 1 Trial Results
PremiumCompany AnnouncementsCorbus Pharmaceuticals Reports Promising Phase 1 Trial Results
2M ago
8K
CRBP
Corbus Pharmaceuticals announces data from its US, UK study of CRB-701
Premium
The Fly
Corbus Pharmaceuticals announces data from its US, UK study of CRB-701
2M ago
CRBP
Corbus Pharmaceuticals announces clinical data for CRB-701
Premium
The Fly
Corbus Pharmaceuticals announces clinical data for CRB-701
2M ago
CRBP
Corbus Pharmaceuticals announes data for CRB-701 from Western Dose study
PremiumThe Fly
Corbus Pharmaceuticals announes data for CRB-701 from Western Dose study
3M ago
CRBP
Corbus Pharmaceuticals announces dosing of first patient in FIH study of CRB-601
PremiumThe Fly
Corbus Pharmaceuticals announces dosing of first patient in FIH study of CRB-601
4M ago
CRBP
Corbus Pharmaceuticals Advances with FDA Fast Track Designation
PremiumCompany Announcements
Corbus Pharmaceuticals Advances with FDA Fast Track Designation
4M ago
8K
CRBP
Corbus Pharmaceuticals announces U.S. FDA granted FTD to CRB-701
PremiumThe Fly
Corbus Pharmaceuticals announces U.S. FDA granted FTD to CRB-701
4M ago
CRBP
Corbus Pharmaceuticals initiated with an Overweight at Piper Sandler
PremiumThe FlyCorbus Pharmaceuticals initiated with an Overweight at Piper Sandler
4M ago
CRBP
Corbus Pharmaceuticals Reports Q3 2024 Financials and Updates
Premium
Company Announcements
Corbus Pharmaceuticals Reports Q3 2024 Financials and Updates
5M ago
CRBP
Corbus Pharmaceuticals price target lowered to $75 from $80 at H.C. Wainwright
Premium
The Fly
Corbus Pharmaceuticals price target lowered to $75 from $80 at H.C. Wainwright
5M ago
CRBP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >